Fauske L, Bruland ØS, Holtermann A, Larsen SG(2026) Experiences and Hopes Among Patients with Colorectal Carcinoma and Peritoneal Metastases Who Are Participating in an Early-Phase Clinical Trial Cancers (Basel), 18(2) DOI 10.3390/cancers18020244, PubMed 41595164
Kristiansen SK, Shubin K, Zubrienė A, Matulis D, Dernjani N, Juzenas P, Bruland ØS, Juzeniene A(2026) Radiobiological investigations of a [212Pb]Pb-carbonic anhydrase IX-targeting small-molecule ligand in renal cell carcinoma and colorectal cancer models Int J Radiat Biol, 102(2), 127-137 DOI 10.1080/09553002.2025.2595630, PubMed 41481374
Larsen RH, Kolstad A, Fosså A, Repetto-Llamazares A, Smerud KT, Illidge T, Bruland ØS(2026) A Phase II Study of 177Lu-Lilotomab Satetraxetan, a CD37 Antibody-Radionuclide Conjugate, as Third- or Later-Line Treatment of Rituximab-Refractory Follicular B-Cell Lymphoma Patients Pharmaceuticals (Basel), 19(2) DOI 10.3390/ph19020250, PubMed 41754790
